Stevens Capital Management LP Abiomed Inc Transaction History

Stevens Capital Management LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 21, 2020	SELL	$130.51 - $196.01 $1.2 Million - $1.8 Million	-9,186 Closed	0 $0
Q4 2019 Feb 06, 2020	SELL	$159.31 - $223.54 $105,463 - $147,983	-662 Reduced 6.72%	9,186 $1.57 Million
Q3 2019 Nov 08, 2019	SELL	$175.89 - $279.23 $651,496 - $1.03 Million	-3,704 Reduced 27.33%	9,848 $1.75 Million
Q2 2019 Jul 31, 2019	SELL	$250.96 - $284.94 $1.76 Million - $2 Million	-7,006 Reduced 34.08%	13,552 $3.53 Million
Q1 2019 May 03, 2019	BUY	$276.39 - $362.25 $1.6 Million - $2.1 Million	5,795 Added 39.25%	20,558 $5.87 Million
Q4 2018 Feb 06, 2019	BUY	$281.08 - $444.25 $4.15 Million - $6.56 Million	14,763 New	14,763 $4.8 Million
Q3 2018 Nov 13, 2018	SELL	$354.53 - $449.75 $4.37 Million - $5.55 Million	-12,330 Closed	0 $0
Q2 2018 Aug 09, 2018	BUY	$278.07 - $446.21 $3.43 Million - $5.5 Million	12,330 New	12,330 $5.04 Million

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Stevens Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Stevens Capital Management LP with notifications on news.